HUE047668T2 - Q10 koenzim szilárd diszperziói - Google Patents

Q10 koenzim szilárd diszperziói

Info

Publication number
HUE047668T2
HUE047668T2 HUE16732249A HUE16732249A HUE047668T2 HU E047668 T2 HUE047668 T2 HU E047668T2 HU E16732249 A HUE16732249 A HU E16732249A HU E16732249 A HUE16732249 A HU E16732249A HU E047668 T2 HUE047668 T2 HU E047668T2
Authority
HU
Hungary
Prior art keywords
coenzyme
solid dispersions
dispersions
solid
Prior art date
Application number
HUE16732249A
Other languages
English (en)
Inventor
Daniele Ciceri
Federico Peterlongo
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HUE047668T2 publication Critical patent/HUE047668T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
HUE16732249A 2015-06-12 2016-06-10 Q10 koenzim szilárd diszperziói HUE047668T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15171943.2A EP3103440A1 (en) 2015-06-12 2015-06-12 Solid dispersions of coenzyme q10

Publications (1)

Publication Number Publication Date
HUE047668T2 true HUE047668T2 (hu) 2020-05-28

Family

ID=53442540

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16732249A HUE047668T2 (hu) 2015-06-12 2016-06-10 Q10 koenzim szilárd diszperziói

Country Status (17)

Country Link
US (1) US10905657B2 (hu)
EP (2) EP3103440A1 (hu)
JP (1) JP6910309B2 (hu)
KR (1) KR20180017016A (hu)
CN (1) CN107750158B (hu)
AU (1) AU2016274662B2 (hu)
CA (1) CA2988478C (hu)
DK (1) DK3307244T3 (hu)
ES (1) ES2768950T3 (hu)
HK (1) HK1250652A1 (hu)
HU (1) HUE047668T2 (hu)
IL (1) IL256159B (hu)
PL (1) PL3307244T3 (hu)
PT (1) PT3307244T (hu)
RU (1) RU2742579C2 (hu)
SI (1) SI3307244T1 (hu)
WO (1) WO2016198576A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11708463B2 (en) 2018-04-06 2023-07-25 Capsugel Belgium Nv Spray drying process for low aspect ratio particles comprising poly[(methyl methacrylate)-co-(methacrylic acid)]
CN111374965B (zh) * 2018-12-28 2024-01-16 上海融澈水性材料有限公司 一种稳定性高的水溶性辅酶q10包合物及其制备方法
IT201900003907A1 (it) 2019-03-18 2020-09-18 Indena Spa Composizioni comprendenti curcumina e coenzima q10
CN114466641A (zh) * 2019-08-30 2022-05-10 三荣源有限公司 含有非结晶的水溶性差的材料的固体组合物及其生产方法
WO2021040027A1 (ja) * 2019-08-30 2021-03-04 三栄源エフ・エフ・アイ株式会社 非晶質の難水溶性素材を含有する固体組成物、及びその製造方法
CN117837754B (zh) * 2024-03-08 2024-05-28 中国农业大学 一种溶解度提高的无定形辅酶q10及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172832A (ja) * 1985-01-28 1986-08-04 Nikko Kemikaruzu Kk 難溶性薬剤含有製剤組成物
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
EP1909762A2 (en) * 2005-07-28 2008-04-16 Isp Investments Inc. Amorphous efavirenz and the production thereof
JP5426165B2 (ja) * 2005-07-28 2014-02-26 アイエスピー インヴェストメンツ インコーポレイテッド 優れた生物学的利用能のベンゾキノン類
JP2007153866A (ja) * 2005-11-09 2007-06-21 Yoshida Kikai Co Ltd 乳化型化粧料
KR100956583B1 (ko) 2006-01-26 2010-05-11 주식회사 대웅제약 유비데카레논의 고체분산체와 그 제조방법 및 이를포함하는 약제학적 조성물
JPWO2007125915A1 (ja) * 2006-04-24 2009-09-10 株式会社カネカ 補酵素q含有固形物
US20080145411A1 (en) 2006-10-06 2008-06-19 Kaneka Corporation Composition of high absorbability for oral administration comprising oxidized coenzyme q10
EP2227085A4 (en) * 2007-12-06 2013-10-09 Berg Pharma Llc INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
US9655849B2 (en) * 2011-03-18 2017-05-23 Particle Dynamics International, Llc Solid particulate compositions comprising coenzyme Q10
CN103536574A (zh) 2013-09-29 2014-01-29 邵爱霞 一种辅酶q10软胶囊及其制备方法

Also Published As

Publication number Publication date
CN107750158A (zh) 2018-03-02
WO2016198576A1 (en) 2016-12-15
HK1250652A1 (zh) 2019-01-11
IL256159A (en) 2018-02-28
CA2988478C (en) 2023-10-03
PT3307244T (pt) 2020-02-03
EP3307244A1 (en) 2018-04-18
ES2768950T3 (es) 2020-06-24
EP3307244B1 (en) 2019-11-20
BR112017026291A2 (pt) 2018-09-11
RU2017142563A3 (hu) 2019-11-28
EP3103440A1 (en) 2016-12-14
JP2018516945A (ja) 2018-06-28
US10905657B2 (en) 2021-02-02
RU2017142563A (ru) 2019-07-12
AU2016274662B2 (en) 2020-08-20
JP6910309B2 (ja) 2021-07-28
KR20180017016A (ko) 2018-02-20
CA2988478A1 (en) 2016-12-15
DK3307244T3 (da) 2020-02-24
RU2742579C2 (ru) 2021-02-08
CN107750158B (zh) 2021-08-27
US20180200201A1 (en) 2018-07-19
SI3307244T1 (sl) 2020-03-31
PL3307244T3 (pl) 2020-05-18
AU2016274662A1 (en) 2018-01-04
IL256159B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
IL250511A0 (en) Crystalline forms of ibrutinib
ZA201700880B (en) Polymorphs of selinexor
SG11201706729SA (en) Derivatives of sobetirome
IL250089A0 (en) Metrology of multiple sampling processes
IL257026A (en) Solid state forms of eluxadoline
HK1250652A1 (zh) 輔酶q10的固體分散體
GB201501583D0 (en) Uses of co-crystals
SI3845221T1 (sl) Trdne oblike sofosbuvirja
IL265628A (en) Solid state forms of valbenazine
HU4602U (en) Set of saggar assembly
PL3102631T3 (pl) Stabilizowane kauczuki
IL246979A0 (en) Crystalline forms of sofosbuvir
ZA201706282B (en) Solid forms of menaquinols
GB201410486D0 (en) Bearing liner
GB201408653D0 (en) Moonpool
GB201417705D0 (en) Locking member
ZA201608686B (en) Interseparation of metals
HK1223624A1 (zh) 替諾福韋的固體形式
GB201602857D0 (en) Connection of rotatable parts
HU4603U (en) Set of saggar assembly
GB2544217B (en) Chlorination of sucrose-6-esters
IL249332A0 (en) Crystalline forms of sofosbuvir
HK1216062A2 (zh) 筆記本支座
GB201414267D0 (en) Chlorination of sucrose-6-esters
GB201516697D0 (en) Serillization of liquids